Heparin-EGF-like factor
Alternative Names: HB-EGFLatest Information Update: 24 Oct 2021
At a glance
- Originator Childrens Hospital Boston; Nonindustrial source
- Developer Nonindustrial source; Scios
- Class Growth factors; Heparins; Intercellular signalling peptides and proteins
- Mechanism of Action Heparin epidermal growth factor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Respiratory distress syndrome; Respiratory tract disorders; Ulcerative colitis
Most Recent Events
- 06 Nov 1995 Discontinued-Preclinical for Respiratory distress syndrome in USA (Unknown route)
- 06 Nov 1995 Discontinued-Preclinical for Respiratory tract disorders in USA (Unknown route)
- 06 Nov 1995 Discontinued-Preclinical for Ulcerative colitis in USA (Unknown route)